Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Pearl Bio
AddedFeb 17, 2024
UpdatedJun 18, 2026
Pearl Bio

Pearl Bio

Seed

Pearl Bio: Pioneering the new era of biologics and biomaterials through synthetic biology.

HQ
Cambridge, MA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Pearl Bio, founded to revolutionize the field of synthetic biology, aims to usher in a new era of biologics and biomaterials. The company's core mission is to harness the power of synthetic biology to develop next-generation biomaterials that can be used in various applications, ranging from medical therapeutics to smart biotechnologies. Pearl Bio's innovative approach focuses on recording life to create advanced biologics, positioning itself at the forefront of the biomaterials market.

Notable figures affiliated with Pearl Bio include leading experts in synthetic biology and biotechnology. The company has attracted significant investment from top-tier venture capital firms, underscoring its potential and credibility in the industry. Key achievements include multiple high-profile press releases and features in major publications like Forbes and Fierce Biotech. Pearl Bio's impact is evident in its pioneering contributions to the development of smart biomaterials, setting new standards in the biotech sector.

Pearl Bio - Similar Companies

Think Bioscience logo

Think Bioscience

Synlife logo

Synlife

synlifebio.com

Twist Bioscience logo

Twist Bioscience

Petri Bio logo

Petri Bio

petribio.com

Bluestem Biosciences logo

Bluestem Biosciences

Satellite Bio logo

Satellite Bio

satellite.bio

Rbio logo

Rbio

rbio.online

Aurita logo

Aurita

auritabio.com

BioHybrid Solutions logo

BioHybrid Solutions

Wild Microbes logo

Wild Microbes

wildmicrobes.com

Perle Bioscience logo

Perle Bioscience

Pneuma logo

Pneuma

pneuma.bio

GentiBio logo

GentiBio

gentibio.com

Orchid BioVentures logo

Orchid BioVentures

Ginkgo Bioworks logo

Ginkgo Bioworks

ginkgobioworks.com

Pearl Bio - Quick Facts

Who are Pearl Bio's competitors?

Companies similar to Pearl Bio include Think Bioscience, Synlife, Twist Bioscience and Petri Bio.

When was Pearl Bio founded?

Pearl Bio was founded in 2020.

Where is Pearl Bio's headquarters located?

Pearl Bio's headquarters is located in Cambridge, MA, US.

When was Pearl Bio's last funding round?

Pearl Bio's most recent funding round was for $4.1M (USD) in October 2021.

How much has Pearl Bio raised to-date?

As of Oct 7, 2021, Pearl Bio has raised a total of $4.1M (USD).

How many employees does Pearl Bio have?

Pearl Bio has 4 employees as of Feb 5, 2024.

Pearl Bio - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
  • Synthetic Biology
Geographic Exposure
  • Global
Model
  • Platform
Customer
  • Enterprise
Main Product
  • Biologics
  • Biomaterials
Tags
  • Biotech
  • Consulting
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified